0001209191-18-047853.txt : 20180821 0001209191-18-047853.hdr.sgml : 20180821 20180821192935 ACCESSION NUMBER: 0001209191-18-047853 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180821 FILED AS OF DATE: 20180821 DATE AS OF CHANGE: 20180821 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cao Han PHD CENTRAL INDEX KEY: 0001745596 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38613 FILM NUMBER: 181031212 MAIL ADDRESS: STREET 1: C/O BIONANO GENOMICS, INC. STREET 2: 9640 TOWNE CENTRE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BioNano Genomics, Inc CENTRAL INDEX KEY: 0001411690 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE BUSINESS ADDRESS: STREET 1: 9640 TOWNE CENTRE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: (858) 888-7600 MAIL ADDRESS: STREET 1: 9640 TOWNE CENTRE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: BioNanomatrix Inc DATE OF NAME CHANGE: 20070906 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2018-08-21 0 0001411690 BioNano Genomics, Inc BNGO 0001745596 Cao Han PHD C/O BIONANO GENOMICS, INC. 9640 TOWNE CENTRE DR #100 SAN DIEGO CA 92121 0 1 0 0 Chief Scientific Officer Common Stock 1413 D Stock Option (right to buy) 291.04 2019-01-14 Common Stock 46 D Stock Option (right to buy) 38.52 2020-04-01 Common Stock 46 D Stock Option (right to buy) 42.80 2021-08-09 Common Stock 2344 D Stock Option (right to buy) 64.20 2025-01-28 Common Stock 1599 D Stock Option (right to buy) 64.20 2025-01-28 Common Stock 2557 D Stock Option (right to buy) 1.28 2027-02-06 Common Stock 51329 D Series B Convertible Preferred Stock 0.00 Common Stock 254275 D Series C Convertible Preferred Stock 0.00 Common Stock 52720 D Series D Convertible Preferred Stock 0.00 Common Stock 4362062 D Series D-1 Convertible Preferred Stock 0.00 Common Stock 104167 D Series D Convertible Preferred Stock Warrant (Right to Buy) 0.41 2016-04-04 2026-03-04 Series D Convertible Preferred Stock 10731083 D The shares subject to the option are fully vested and exercisable. 25% of the shares vested on January 29, 2016, and the remaining shares vest in 12 equal quarterly installments thereafter. 25% of the shares vested on February 7, 2017, and the remaining shares vest in 12 equal quarterly installments thereafter. The convertible preferred stock is convertible at any time at the holder's election and automatically converts upon the consummation of a qualified public offering of the registrant. There is no expiration date for any series of preferred stock. /s/ Han Cao, Ph.D. 2018-08-21